An evaluation of anti-TNF-alpha-therapy in patients with ankylosing spondylitis: imbalanced activation of NF kappa B subunits in lymphocytes and modulation of serum cortisol concentration. [electronic resource]
Producer: 20080404Description: 841-6 p. digitalISSN:- 0172-8172
- Adult
- Aged
- Antibodies, Monoclonal -- administration & dosage
- Antirheumatic Agents -- administration & dosage
- Biomarkers -- analysis
- C-Reactive Protein -- drug effects
- DNA-Binding Proteins -- drug effects
- Female
- Humans
- Hydrocortisone -- blood
- Infliximab
- Interleukin-6 -- blood
- Lymphocytes -- drug effects
- Male
- Middle Aged
- NF-kappa B -- drug effects
- NF-kappa B p50 Subunit -- drug effects
- Spondylitis, Ankylosing -- blood
- Transcription Factor RelA -- drug effects
- Transcriptional Activation -- drug effects
- Tumor Necrosis Factor-alpha -- antagonists & inhibitors
No physical items for this record
Publication Type: Clinical Trial; Journal Article
There are no comments on this title.
Log in to your account to post a comment.